| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $5.5B | $4.7B | $3.3B | $2.8B | $2.8B |
| Cost of Revenue | $0.7B | $1.2B | $1.1B | $1.3B | $1.0B |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $0.2B | $0.6B | $0.6B | $0.5B | $0.4B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $4.2B | $1.9B | $0.6B | $-0.0B | $0.2B |
| Net Income | $3.3B | $1.6B | $0.4B | $-0.2B | $0.0B |
| EPS (Basic) | $9.84 | $4.68 | $1.01 | $-0.52 | $0.10 |
| EPS (Diluted) | $9.75 | $4.53 | $0.98 | $-0.52 | $0.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $7.3B | $5.9B | $5.4B | $5.8B | $6.2B |
| Current Assets | $4.4B | $2.3B | $1.6B | $1.9B | $3.2B |
| Cash & Equivalents | $2.5B | $0.7B | $0.5B | $1.1B | $1.5B |
| Total Liabilities | $5.1B | $4.8B | $4.1B | $3.9B | $4.0B |
| Current Liabilities | $1.3B | $1.1B | $0.9B | $0.6B | $0.6B |
| Stockholders' Equity | $2.1B | $1.1B | $1.3B | $1.9B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.0B | $2.1B | $1.1B | $0.4B | $0.4B |
| Investing Cash Flow | $0.4B | $-0.1B | $-0.1B | $-1.4B | $-1.2B |
| Capital Expenditures | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-2.6B | $-1.7B | $-1.6B | $-0.5B | $3.1B |